Millennium Management’s Trinity Biotech TRIB Stock Holding History

Millennium Management’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,093	Closed	-$6.63K	–	6658
2023 Q4	$6.63K	Buy	+3,093	New	+$7.38K	﹤0.01%	5784
2022 Q2	–	Sell	-8,473	Closed	-$45K	–	7511
2022 Q1	$45K	Buy	8,473 +322	+4%	+$1.85K	﹤0.01%	6424
2021 Q4	$58K	Sell	8,151 -4,734	-37%	-$44.7K	﹤0.01%	6440
2021 Q3	$139K	Buy	+12,885	New	+$151K	﹤0.01%	6282
2021 Q2	–	Sell	-11,804	Closed	-$222K	–	7113
2021 Q1	$222K	Sell	11,804 -7,698	-39%	-$185K	﹤0.01%	5437
2020 Q4	$372K	Buy	19,502 +16,046	+464%	+$266K	﹤0.01%	4426
2020 Q3	$35	Buy	+3,456	New	+$40K	﹤0.01%	4321
2020 Q2	–	Sell	-21,797	Closed	-$120K	–	4602
2020 Q1	$120K	Sell	21,797 -9,825	-31%	-$51.4K	﹤0.01%	3512
2019 Q4	$163K	Buy	31,622 +618	+2%	+$2.94K	﹤0.01%	3924
2019 Q3	$187K	Sell	31,004 -1,014	-3%	-$8.81K	﹤0.01%	3812
2019 Q2	$296K	Buy	32,018 +1,040	+3%	+$12.4K	﹤0.01%	3550
2019 Q1	$441K	Sell	30,978 -251	-0.8%	-$3.45K	﹤0.01%	3349
2018 Q4	$358K	Sell	31,229 -1,671	-5%	-$25.8K	﹤0.01%	3139
2018 Q3	$658K	Sell	32,900 -1,042	-3%	-$22.6K	﹤0.01%	3096
2018 Q2	$849K	Sell	33,942 -36,886	-52%	-$887K	﹤0.01%	2931
2018 Q1	$1.82M	Sell	70,828 -9,889	-12%	-$270K	﹤0.01%	2370
2017 Q4	$2.06M	Buy	80,717 +13,893	+21%	+$358K	﹤0.01%	2269
2017 Q3	$1.87M	Sell	66,824 -8,252	-11%	-$230K	﹤0.01%	2201
2017 Q2	$2.25M	Sell	75,076 -595	-0.8%	-$16.9K	﹤0.01%	2008
2017 Q1	$2.25M	Sell	75,671 -38,989	-34%	-$1.22M	﹤0.01%	1942
2016 Q4	$3.97M	Buy	114,660 +51,396	+81%	+$1.77M	0.01%	1481
2016 Q3	$4.18M	Buy	63,264 +15,448	+32%	+$962K	0.01%	1448
2016 Q2	$2.71M	Buy	47,816 +12,415	+35%	+$700K	0.01%	1627
2016 Q1	$2.06M	Sell	35,401 -69,219	-66%	-$3.67M	0.01%	1755
2015 Q4	$6.15M	Buy	104,620 +58,101	+125%	+$3.43M	0.01%	1225
2015 Q3	$2.66M	Buy	46,519 +36,473	+363%	+$2.93M	0.01%	1723
2015 Q2	$907K	Sell	10,046 -63,604	-86%	-$5.51M	﹤0.01%	2334
2015 Q1	$7.09M	Buy	73,650 +10,977	+18%	+$1.01M	0.01%	1227
2014 Q4	$5.49M	Buy	+62,673	New	+$5.4M	0.01%	1333
2014 Q3	–	Sell	-2,122	Closed	-$244K	–	4017
2014 Q2	$244K	Buy	+2,122	New	+$251K	﹤0.01%	2996

Other funds holding TRIB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

WCM

Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return

MAWA

Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

BCM

Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management's TRIB Position: Q1 2024 in Review

Millennium Management sold out of Trinity Biotech (TRIB) in Q1 2024, closing a stake of 3,093 shares — an estimated $6.63K sold.

Millennium Management first reported a position in TRIB in Q2 2014 and held it in 30 quarters. The position peaked at $7.09M in Q1 2015. 19 funds tracked by Wall St. Rank hold TRIB as of Q1 2024.

Millennium Management reported no remaining Trinity Biotech position as of Q1 2024 after selling out during the quarter.
Millennium Management sold 3,093 Trinity Biotech shares in Q1 2024, an estimated $6.63K.
Millennium Management first reported a position in Trinity Biotech in Q2 2014 and held it in 30 quarters.
Millennium Management's Trinity Biotech position peaked at $7.09M in Q1 2015.
19 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.